The growing complexity of the connected vehicle ecosystem has expanded the breadth of potential cybersecurity risks for OEMs.

Automotive cybersecurity company Upstream Security Inc. today announced a new strategic partnership with Škoda Auto a.s. to ...

Upstream Bio's IPO raised ~$293m, focusing on developing verekitug, a unique TSLP receptor antagonist for severe respiratory disorders, now in Phase 2 trials. The company has a strong cash position of ...

In a year when the sector was buffeted by geopolitical, economic, corporate, financial and technical developments, Upstream was on-hand to bring exclusive news and insight to subscribers ...

– Global Phase 2 clinical trial, VENTURE, to evaluate the efficacy and safety of verekitug administered every 12 or 24 weeks in moderate-to-severe COPD – – Broadens global development program for ...